CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers http://www.globenewswire.com/news-release/2021/01/08/2155496/0/en/CareDx-Agrees-to-Acquire-TransChart-and-Expands-EMR-Connectivity-to-Over-90-Centers.html Acquisition will build on CareDx’s digital capabilities and continue deepening the moat with transplant centers ...

CareDx Announces AlloID and Exclusive Partnership with IDbyDNA https://www.globenewswire.com/news-release/2021/01/07/2154794/0/en/CareDx-Announces-AlloID-and-Exclusive-Partnership-with-IDbyDNA.html AlloID is a Transplant Patient-Specific Metagenomic Infectious Disease Test Platform, Furthering CareDx’s Innovation in Multi-Modality Surveillance Care ...

CareDx’s AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance https://www.globenewswire.com/news-release/2021/01/04/2152520/0/en/CareDx-s-AlloSeq-HCT-Wins-Tender-for-French-Stem-Cell-Transplant-Patient-Surveillance.html CareDx wins a 2-year competitive tender with the French National Blood Service, Établissement Français du Sang ...

CareDx: Stock To Achieve Significant Long-Term Growth https://seekingalpha.com/article/4397022-caredx-stock-to-achieve-significant-long-term-growth Summary CareDx offers organ testing products that are non-invasive alternatives to more invasive traditional tests. The organ transplant market is expected to grow through 2027, creating a tailwind for CareDx. While the company's growth is strong and above-average, the valuation and near overbought level needs to be considered. ...

CareDx Celebrates the Long-Awaited Passage of the Immuno Bill http://www.globenewswire.com/news-release/2020/12/22/2149535/0/en/CareDx-Celebrates-the-Long-Awaited-Passage-of-the-Immuno-Bill.html Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients ...

CareDx price target raised to $75 from $62 at Raymond James https://thefly.com/landingPageNews.php?id=3210563&headline=CDNA-CareDx-price-target-raised-to--from--at-Raymond-James

CareDx Announces First AlloSure Pediatrics Publication https://www.einnews.com/pr_news/531827412/caredx-announces-first-allosure-pediatrics-publication

CareDx Receives Medicare Reimbursement Pricing for AlloSure Heart https://finance.yahoo.com/news/caredx-receives-medicare-reimbursement-pricing-100000177.html

New Publication Shows CareDx’s AlloSure May Be Effective for Monitoring BK Virus in Transplant Patients https://www.globenewswire.com/news-release/2020/11/06/2121914/0/en/New-Publication-Shows-CareDx-s-AlloSure-May-Be-Effective-for-Monitoring-BK-Virus-in-Transplant-Patients.html

Bzw in Kurzform: CareDx EPS beats by $0.16, beats on revenue https://seekingalpha.com/news/3628594-caredx-eps-beats-0_16-beats-on-revenue CareDx (NASDAQ:CDNA): Q3 Non-GAAP EPS of $0.10 beats by $0.16; GAAP EPS of -$0.06 beats by $0.14. Revenue of $53.37M (+57.9% Y/Y) beats by $1.47M.

https://seekingalpha.com/pr/18065178-caredx-reports-third-quarter-2020-results?_gl=1*1vnn74t*_ga*WmNZYjIxOFBHQmxyemg5aEJpVUZNYnI5bVVGRE40RElZVE1MMFRrWFFnLVkwbm5IYXU2aUFVME1vRG9mMEV0Uw..

https://finance.yahoo.com/news/medicare-proposes-maintain-current-reimbursement-110500235.html?theme=2&_v=1&color=1&hl=en&sp=1

CareDx Reports Preliminary Third Quarter 2020 Revenue https://www.globenewswire.com/news-release/2020/10/07/2105201/0/en/CareDx-Reports-Preliminary-Third-Quarter-2020-Revenue.html

CareDx Announces Publication of Pivotal AlloSure Lung Data https://finance.yahoo.com/news/caredx-announces-publication-pivotal-allosure-110000879.html

CareDx Receives Final Medicare Coverage Decision for AlloSure Heart Final decision on AlloSure Heart paves the way for HeartCare, the most comprehensive multi-modality tool available to heart transplant patients https://www.globenewswire.com/news-release/2020/10/01/2102331/0/en/CareDx-Receives-Final-Medicare-Coverage-Decision-for-AlloSure-Heart.html

.